ENDRA Life Sciences (NDRA) Return on Sales (2016 - 2018)

ENDRA Life Sciences has disclosed Return on Sales across 3 years of filings, most recently posting 15.87% for Q4 2018.

• In Q4 2018, Return on Sales fell 1252.0% year-over-year to 15.87%; the TTM figure through Dec 2018 stood at 15.87% (down 1571.0% YoY), while the FY2018 annual figure was 15.87%, down 1571.0% from the prior year.
• Return on Sales retreated to 15.87% in Q4 2018, from 7.47% in the prior quarter.
• Over the last five years, Return on Sales for NDRA reached as high as 0.01% in Q4 2016 and fell as low as 15.87% in Q4 2018.
• The 3-year median for Return on Sales is 1.81% (2018), against an average of 3.98%.
• The widest YoY moves for Return on Sales: up 1 bps in 2018, down 1252 bps in 2018.
• A 3-year view of Return on Sales shows it stood at 0.01% in 2016, then sank by 24971 bps to 3.35% in 2017, then slumped by 374 bps to 15.87% in 2018.
• According to Business Quant data, Return on Sales over the past three periods registered 15.87%, 7.47%, and 0.26% for Q4 2018, Q3 2018, and Q2 2018 respectively.